Amino acid substitutions account for most mexS alterations in clinical nfxC mutants of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 4, 2016, Pages 2302-2310

  Richardot, Charlotte ^a   Juarez, Paulo ^a   Jeannot, Katy ^a,b   Patry, Isabelle ^b   Plésiat, Patrick ^a,b   Llanes, Catherine ^a  

^a Université Bourgogne Franche Comté   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL ENZYME; BACTERIAL PROTEIN; NFXC PROTEIN; OXIDOREDUCTASE; OXIDOREDUCTASE MEXS; UNCLASSIFIED DRUG; VIRULENCE FACTOR; ANTIINFECTIVE AGENT; CIPROFLOXACIN; IMIPENEM; MEXXY PROTEIN, PSEUDOMONAS AERUGINOSA; OPRN PROTEIN, PSEUDOMONAS AERUGINOSA; OUTER MEMBRANE PROTEIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM MUTANT; CONTROLLED STUDY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; UPREGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; MUTATION; OPERON; PSEUDOMONAS INFECTIONS;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MUTATION; OPERON; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VIRULENCE FACTORS;

EID: 84963517163     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02622-15     Document Type: Article

References (45)

1. Gellatly SL, Hancock RE. 2013. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. PathogDis 67:159-173. http://dx.doi.org/10.1111/2049-632X.12033.
2. Poole K, Srikumar R. 2001. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr Top Med Chem 1:59-71. http://dx.doi.org/10.2174/1568026013395605.
3. Köhler T, Michea-Hamzehpour M, Henze U, Gotoh N, Curty LK, Pechère JC. 1997. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 23:345-354. http://dx.doi.org/10.1046/j.1365-2958.1997.2281594.x.
4. Li XZ, Barre N, Poole K. 2000. Influence of the MexA-MexB-OprM multidrug efflux system on expression of the MexC-MexD-OprJ and MexE-MexF-OprN multidrug efflux systems in Pseudomonas aeruginosa. J Antimicrob Chemother 46:885-893. http://dx.doi.org/10.1093/jac/46.6.885.
5. Schweizer HP. 2003. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res 2:48-62.
6. Köhler T, Epp SF, Curty LK, Pechère JC. 1999. Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol 181:6300-6305.
7. Maseda H, Saito K, Nakajima A, Nakae T. 2000. Variation of the mexT gene, a regulator of the MexEF-OprN efflux pump expression in wild-type strains of Pseudomonas aeruginosa. FEMS Microbiol Lett 192:107-112. http://dx.doi.org/10.1111/j.1574-6968.2000.tb09367.x.
8. Sobel ML, Hocquet D, Cao L, Plesiat P, Poole K. 2005. Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 49:1782-1786. http://dx.doi.org/10.1128/AAC.49.5.1782-1786.2005.
9. Tian ZX, Fargier E, MacAogain M, Adams C, Wang YP, O'Gara F. 2009. Transcriptome profiling defines a novel regulon modulated by the LysR-type transcriptional regulator MexT in Pseudomonas aeruginosa. Nucleic Acids Res 37:7546-7559. http://dx.doi.org/10.1093/nar/gkp828.
10. Fargier E, MacAogain M, Mooij MJ, Woods DF, Morrissey JP, Dobson AD, Adams C, O'Gara F. 2012. MexT functions as a redox-responsive regulator modulating disulfide stress resistance in Pseudomonas aeruginosa. J Bacteriol 194:3502-3511. http://dx.doi.org/10.1128/JB.06632-11.
11. Frisk A, Schurr JR, Wang G, Bertucci DC, Marrero L, Hwang SH, Hassett DJ, Schurr MJ. 2004. Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells. Infect Immun 72:5433-5438. http://dx.doi.org/10.1128/IAI.72.9.5433-5438.2004.
12. Llanes C, Köhler T, Patry I, Dehecq B, van Delden C, Plésiat P. 2011. Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin. Antimicrob Agents Chemother 55:5676-5684. http://dx.doi.org/10.1128/AAC.00101-11.
13. Westfall LW, Carty NL, Layland N, Kuan P, Colmer-Hamood JA, Hamood AN. 2006. mvaT mutation modifies the expression of the Pseudomonas aeruginosa multidrug efflux operon mexEF-oprN. FEMS Microbiol Lett 255:247-254. http://dx.doi.org/10.1111/j.1574-6968.2005.00075.x.
14. Balasubramanian D, Schneper L, Merighi M, Smith R, Narasimhan G, Lory S, Mathee K. 2012. The regulatory repertoire of Pseudomonas aeruginosa AmpC -lactamase regulator AmpR includes virulence genes. PLoS One 7:e34067. http://dx.doi.org/10.1371/journal.pone.0034067.
15. Zaoui C, Overhage J, Lons D, Zimmermann A, Musken M, Bielecki P, Pustelny C, Becker T, Nimtz M, Haussler S. 2012. An orphan sensor kinase controls quinolone signal production via MexT in Pseudomonas aeruginosa. Mol Microbiol 83:536-547. http://dx.doi.org/10.1111/j.1365-2958.2011.07947.x.
16. Köhler T, van Delden C, Curty LK, Hamzehpour MM, Pechère JC. 2001. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J Bacteriol 183:5213-5222. http://dx.doi.org/10.1128/JB.183.18.5213-5222.2001.
17. Olivares J, Alvarez-Ortega C, Linares JF, Rojo F, Köhler T, Martinez JL. 2012. Overproduction of the multidrug efflux pump MexEF-OprN does not impair Pseudomonas aeruginosa fitness in competition tests, but produces specific changes in bacterial regulatory networks. Environ Microbiol 14:1968-1981. http://dx.doi.org/10.1111/j.1462-2920.2012.02727.x.
18. Linares JF, Lopez JA, Camafeita E, Albar JP, Rojo F, Martinez JL. 2005. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J Bacteriol 187:1384-1391. http://dx.doi.org/10.1128/JB.187.4.1384-1391.2005.
19. Lamarche MG, Deziel E. 2011. MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline). PLoS One 6:e24310. http://dx.doi.org/10.1371/journal.pone.0024310.
20. Jalal S, Ciofu O, Hoiby N, Gotoh N, Wretlind B. 2000. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 44:710-712. http://dx.doi.org/10.1128/AAC.44.3.710-712.2000.
21. Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Merens A, GERPA Study Group. 2013. Diversity of [3-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study. J Antimicrob Chemother 68:1763-1771. http://dx.doi.org/10.1093/jac/dkt115.
22. Fukuda H, Hosaka M, Hirai K, Iyobe S. 1990. New norfloxacin resistance gene in Pseudomonas aeruginosa PAO. Antimicrob Agents Chemother 34:1757-1761. http://dx.doi.org/10.1128/AAC.34.9.1757.
23. Pumbwe L, Piddock LJ. 2000. Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 44:2861-2864. http://dx.doi.org/10.1128/AAC.44.10.2861-2864.2000.
24. Oh H, Stenhoff J, Jalal S, Wretlind B. 2003. Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinoloneresistant Pseudomonas aeruginosa strains. Microb Drug Resist 9:323-328. http://dx.doi.org/10.1089/107662903322762743.
25. Ditta G, Stanfield S, Corbin D, Helinski DR. 1980. Broad host range DNA cloning system for gram-negative bacteria: construction of a gene bank of Rhizobium meliloti. Proc Natl Acad Sci US A 77:7347-7351. http://dx.doi.org/10.1073/pnas.77.12.7347.
26. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. M07-A8, vol 29. Clinical and Laboratory Standards Institute, Wayne, PA
27. Dumas JL, van Delden C, Perron K, Köhler T. 2006. Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol Lett 254:217-225. http://dx.doi.org/10.1111/j.1574-6968.2005.00008.x.
28. Vasseur P, Soscia C, Voulhoux R, Filloux A. 2007. PelC is a Pseudomonas aeruginosa outer membrane lipoprotein of the OMA family of proteins involved in exopolysaccharide transport. Biochimie 89:903-915. http://dx.doi.org/10.1016/j.biochi.2007.04.002.
29. Köhler T, Curty LK, Barja F, van Delden C, Pechère JC. 2000. Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J Bacteriol 182:5990-5996. http://dx.doi.org/10.1128/JB.182.21.5990-5996.2000.
30. Ohman DE, Cryz SJ, Iglewski BH. 1980. Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase. J Bacteriol 142:836-842.
31. Essar DW, Eberly L, Hadero A, Crawford IP. 1990. Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications. J Bacteriol 172:884-900.
32. Kaniga K, Delor I, Cornelis GR. 1991. A wide-host-range suicide vector for improving reverse genetics in gram-negative bacteria: inactivation of the blaA gene of Yersinia enterocolitica. Gene 109:137-141. http://dx.doi.org/10.1016/0378-1119 (91) 90599-7.
33. Hoang TT, Kutchma AJ, Becher A, Schweizer HP. 2000. Integrationproficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineeringof reporter and expression strains. Plasmid 43:59-72. http://dx.doi.org/10.1006/plas.1999.1441.
34. Tian ZX, MacAogain M, O'Connor HF, Fargier E, Mooij MJ, Adams C, Wang YP, O'Gara F. 2009. MexT modulates virulence determinants in Pseudomonas aeruginosa independent of the MexEF-OprN efflux pump. Microb Pathog 47:237-241. http://dx.doi.org/10.1016/j.micpath.2009.08.003.
35. Jin Y, Yang H, Qiao M, Jin S. 2011. MexT regulates the type III secretion system through MexS and PtrC in Pseudomonas aeruginosa. J Bacteriol 193:399-410. http://dx.doi.org/10.1128/JB.01079-10.
36. Kumar A, Schweizer HP. 2011. Evidence of MexT-independent overexpression of MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa in presence ofmetabolic stress. PLoS One 6:e26520. http://dx.doi.org/10.1371/journal.pone.0026520.
37. Köhler T, Michea-Hamzehpour M, Plesiat P, Kahr AL, Pechere JC. 1997. Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 41:2540-2543.
38. Fournier D, Richardot C, Muller E, Robert-Nicoud M, Llanes C, Plesiat P, Jeannot K. 2013. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa. J Antimicrob Chemother 68:1772-1780. http://dx.doi.org/10.1093/jac/dkt098.
39. Maseda H, Sawada I, Saito K, Uchiyama H, Nakae T, Nomura N. 2004. Enhancement of the mexAB-oprM efflux pump expression by a quorumsensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa. Antimicrob Agents Chemother 48:1320-1328. http://dx.doi.org/10.1128/AAC.48.4.1320-1328.2004.
40. Craven SH, Ezezika OC, Haddad S, Hall RA, Momany C, Neidle EL. 2009. Inducer responses of BenM, a LysR-type transcriptional regulator fromAcinetobacter baylyi ADP1. Mol Microbiol 72:881-894. http://dx.doi.org/10.1111/j.1365-2958.2009.06686.x.
41. Colyer TE, Kredich NM. 1996. In vitro characterization of constitutive CysB proteins from Salmonella typhimurium. Mol Microbiol 21:247-256. http://dx.doi.org/10.1046/j.1365-2958.1996.6301347.x.
42. Morita Y, Tomida J, Kawamura Y. 2015. Efflux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon. Front Microbiol 6:8. http://dx.doi.org/10.3389/fmicb.2015.00008.
43. Manoil C, Beckwith J. 1985. TnphoA: a transposon probe for protein export signals. Proc Natl Acad Sci U S A 82:8129-8133. http://dx.doi.org/10.1073/pnas.82.23.8129.
44. Herrero M, de Lorenzo V, Timmis KN. 1990. Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria. J Bacteriol 172:6557-6567.
45. Lacks S, Greenberg B. 1977. Complementary specificity of restriction endonucleases of Diplococcus pneumoniae with respect to DNA methylation. J Mol Biol 114:153-168. http://dx.doi.org/10.1016/0022-2836 (77) 90289-3.